Yang et al., 1997 - Google Patents
Depletion of eosinophil infiltration by anti-IL-5 monoclonal antibody (TRFK-5) accelerates open skin wound epithelial closureYang et al., 1997
View PDF- Document ID
- 6496198207325153656
- Author
- Yang J
- Torio A
- Donoff R
- Gallagher G
- Egan R
- Weller P
- Wong D
- Publication year
- Publication venue
- The American journal of pathology
External Links
Snippet
Wound healing is critical to the survival of the species after injury. Using hamsters as an experimental model, we have shown that eosinophils infiltrate prominently into skin wounds and that they express transforming growth factor-alpha and-beta 1 mRNAs and proteins. We …
- 210000003979 Eosinophils 0 title abstract description 92
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/06—Organic compounds, e.g. mineral oil, petrolatum, synthetic polyolefins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Yang et al. | Depletion of eosinophil infiltration by anti-IL-5 monoclonal antibody (TRFK-5) accelerates open skin wound epithelial closure | |
| US7052684B2 (en) | Methods of healing wounds and fibrotic disorders using IL-10 | |
| Haynes et al. | Platelet-derived growth factor induces fetal wound fibrosis | |
| EP0579626B1 (en) | Method and agents for promoting wound healing | |
| DE69316921T2 (en) | NEW USES FOR IL-10 | |
| Sullivan et al. | A model of scarless human fetal wound repair is deficient in transforming growth factor beta | |
| Gilhar et al. | Hair growth in scalp grafts from patients with alopecia areata and alopecia universalis grafted onto nude mice | |
| EA003394B1 (en) | Insoluble compositions, containing insulin, methods for preparing, suspension medication, method of treatment from diabetes and hyperglycemia | |
| KR101514414B1 (en) | Methods for treating diabetic foot ulcers | |
| CA3035830A1 (en) | Topical erythropoietin formulations and methods for improving wound healing with and cosmetic use of the formulations | |
| EP1059928A1 (en) | Inorganic nitrite and organic acid in combination as topical antiviral composition | |
| TR201807769T4 (en) | A novel method of treating spinal cord injury using the HMGB1 fragment. | |
| EP0443224A1 (en) | Use of thrombospondin to promote wound healing | |
| Chen et al. | Obstruction of the formation of granulation tissue leads to delayed wound healing after scald burn injury in mice | |
| US5202118A (en) | Method for promoting wound healing using IL-1 | |
| Ma et al. | Walnut oil promotes healing of wounds and skin defects in rats via regulating the NF-kB pathway | |
| Cantor | Bleomycin-induced pulmonary fibrosis | |
| Houghton et al. | The role of transforming growth factor‐β in the conversion from “scarless” healing to healing with scar formation | |
| EP0393140B1 (en) | Topical wound-healing preparations comprising interleukin-1 proteins | |
| Kiritsy et al. | Combination of platelet‐derived growth factor‐BB and insulin‐like growth factor‐I is more effective than platelet‐derived growth factor‐BB alone in stimulating complete healing of full‐thickness wounds in “older” diabetic mice | |
| WO2017066605A1 (en) | Sequential application of macrophages for wound healing | |
| EP3288579A1 (en) | A novel skin medical and cosmetic care product | |
| Rich et al. | Stimulation of corneal endothelial wound healing in cats by mesodermal growth factor | |
| CN116832143A (en) | PDGF preparation for healing wound surface of full-layer skin injury | |
| Kovalchuk et al. | Natural complex of cytokines is a potent stimulant to posttraumatic regeneration in rabbit cornea |